Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.390
+0.140 (3.29%)
At close: Jul 17, 2026, 4:00 PM EDT
4.420
+0.030 (0.68%)
After-hours: Jul 17, 2026, 4:50 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $106.06 million as of July 17, 2026. Its market cap has decreased by -30.69% in one year.
Market Cap
106.06M
Enterprise Value
111.69M
1-Year Change
-30.69%
Ranking
Category
Stock Price
$4.39
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $106.06M, an increase of 68.07%. That is a compound annual growth rate of 7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 106.06M | -23.03% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 898.56M |
| Castle Biosciences | 732.77M |
| Myriad Genetics | 583.69M |
| Fulgent Genetics | 572.56M |
| Biodesix | 209.08M |
| Insight Molecular Diagnostics | 153.06M |
| Burning Rock Biotech | 105.15M |
| Precipio | 44.04M |